Sort publications on year
-
Prise en charge de l’insuffisance cardiaque sévère dans l’étude EPICAL en Lorraine
FAGNANI F, BUTEAU L, VIRION JM, BRIANCON S, ZANNAD F
Thérapie ; 2001;56(1):5-10
-
Pharmaco - Epidemiology
Pregnancy-induced changes in lower extremity superficial veins: an ultrasound scan study
BOIVIN P, CORNU-THENARD A, CHARPAK Y
J Vasc Surg ; 2000;32:570-574
-
Pharmaco - Epidemiology
Epidémiologie de l’insuffisance cardiaque en France : approche médico-économique
FAGNANI F
La Lettre du Cardiologue 1er Trimestre 2000 ; IV-VI
-
Pharmaco-Economics
Economic evaluation of enoxaparin versus heparin in unstable angina: a French sub-study of the ESSENCE trial
DETOURNAY B, HUET X, FAGNANI F, MONTALESCOT G
PharmacoEconomics ; 2020;18(1):83-89
-
Biometry and database analysis
Outcomes and management costs of peripheral artery disease in France
BURA RIVIERE A, BOUEE S, LAURENDEAU C, TORRETON E, GOURMELEN J, THOMAS-DELECOURT F.
J Vasc Surg ; 2018;67(6):1834-1843
-
Others
DEPIVIH 2: Use of three HIV testing methods in French primary care settings – ELISA laboratory screening versus two rapid point-of-care HIV tests.
PAPADIMA D, GAUTHIER R, PREVOTEAU DU CLARY F, BOUEE S, CONORT G, LIVROZET JM, TAULERA O, WAJSBROT A, MAJERHOLC C, PETER JM, AUBERT JP
Med Mal Infect ; 2018;48(2018):122-129
-
Pharmaco-Economics
Conséquences économiques du suivi biologique et des complications médicales en lien avec l’utilisation des anticoagulants injectables en France.
PAUBEL P, COUSIN M, AMAR C, GOURMELEN J, FABRON C, DETOURNAY B
J Mal Vasc ; 2016;41:371-377
-
Biometry and database analysis
Outcomes following acute hospitalised myocardial infarction in France: An insurance claims database analysis
BLIN P, PHILIPPE F, BOUEE S, LAURENDEAU C, TORRETON E, GOURMELIN J, LEPROUST S , LEVY-BACHELOT L, STEG PG
Int J Cardiol - 2016 ; 219 : 387-393
-
Pharmaco - Epidemiology
Incidence of venous thromboembolism in France: a retrospective analysis of a national insurance claims database.
BOUEE S, EMERY C, SAMSON A, GOURMELEN J, BAILLY C, COTTE FE.
Thromb J. ; 2016;14(4)
-
Pharmaco - Epidemiology
Incidence of Cardiovascular Events Following Myocardial Infarction in France: an Observational Analysis Using a Claims Database.
PHILIPPE F, BLIN P, LAURENDEAU C, BOUEE S, GOURMELEN J, LEVY BACHELOT L, LEPROUST S, STEG PG.
Value Health ; 2015;18(7):A382
-
Pharmaco-Economics
Increased Costs Due To Myocardial Infarction (Mi) In France: An Observational Analysis Using A Claims Database.
BLIN P, PHILIPPE F, LAURENDEAU C, BOUEE S, GOURMELEN J, LEVY BACHELOT L, LEPROUST S, STEG PG.
Value Health ; 2015;18(7):A386
-
Pharmaco - Epidemiology
Characteristics and management of outpatients with history of or current atrial fibrillation : the observational French EPHA study
COHEN A, DALLONGEVILLE J, DURAND-ZALESKI I, BOUÉE S, LE HEUZEY JY, the EPHA Investigators
Arch Cardiovasc Dis ; 2010;103(6-7):376-387
-
Pharmaco - Epidemiology
Epidemiology of atrial fibrillation in France : extrapolation of international epidemiological data to France and analysis of french hospitalization data
CHARLEMAGNE A, BLACHER J, COHEN A, COLLET JP, DIEVART F, DE GROOTE P, HANON O, LEENARDT A, PINEL JF, PISICA-DONOSE G, LE HEUZEY JY
Arch Cardiovasc Dis ; 2011;104:115-124
-
Pharmaco-Economics
Long term treatment of atrial fibrillation in elderly patients: A decision analysis
LAFUENTE C, EMERY C, LAURENDEAU C, FAGNANI F, BERGMANN JF
Int J Cardiol ; 2012;155(1):102-109